File Download

There are no files associated with this item.

  • Find it @ UNIST can give you direct access to the published full text of this article. (UNISTARs only)
Related Researcher

서판길

Suh, Pann-Ghill
Read More

Views & Downloads

Detailed Information

Cited time in webofscience Cited time in scopus
Metadata Downloads

Full metadata record

DC Field Value Language
dc.citation.endPage 1682 -
dc.citation.number 11 -
dc.citation.startPage 1674 -
dc.citation.title EXPERIMENTAL AND MOLECULAR MEDICINE -
dc.citation.volume 53 -
dc.contributor.author Lee, Byeong Eun -
dc.contributor.author Suh, Pann-Ghill -
dc.contributor.author Kim, Jae-Ick -
dc.date.accessioned 2023-12-21T15:07:41Z -
dc.date.available 2023-12-21T15:07:41Z -
dc.date.created 2021-11-27 -
dc.date.issued 2021-11 -
dc.description.abstract O-GlcNAcylation is a posttranslational modification that adds O-linked β-N-acetylglucosamine (O-GlcNAc) to serine or threonine residues of many proteins. This protein modification interacts with key cellular pathways involved in transcription, translation, and proteostasis. Although ubiquitous throughout the body, O-GlcNAc is particularly abundant in the brain, and various proteins commonly found at synapses are O-GlcNAcylated. Recent studies have demonstrated that the modulation of O-GlcNAc in the brain alters synaptic and neuronal functions. Furthermore, altered brain O-GlcNAcylation is associated with either the etiology or pathology of numerous neurodegenerative diseases, while the manipulation of O-GlcNAc exerts neuroprotective effects against these diseases. Although the detailed molecular mechanisms underlying the functional roles of O-GlcNAcylation in the brain remain unclear, O-GlcNAcylation is critical for regulating diverse neural functions, and its levels change during normal and pathological aging. In this review, we will highlight the functional importance of O-GlcNAcylation in the brain and neurodegenerative diseases. -
dc.identifier.bibliographicCitation EXPERIMENTAL AND MOLECULAR MEDICINE, v.53, no.11, pp.1674 - 1682 -
dc.identifier.doi 10.1038/s12276-021-00709-5 -
dc.identifier.issn 1226-3613 -
dc.identifier.scopusid 2-s2.0-85119972435 -
dc.identifier.uri https://scholarworks.unist.ac.kr/handle/201301/54958 -
dc.identifier.url https://www.nature.com/articles/s12276-021-00709-5 -
dc.identifier.wosid 000722834300002 -
dc.language 영어 -
dc.publisher SPRINGERNATURE -
dc.title O-GlcNAcylation in health and neurodegenerative diseases -
dc.type Article -
dc.description.isOpenAccess FALSE -
dc.relation.journalWebOfScienceCategory Biochemistry & Molecular Biology; Medicine, Research & Experimental -
dc.identifier.kciid ART002781246 -
dc.relation.journalResearchArea Biochemistry & Molecular Biology; Research & Experimental Medicine -
dc.type.docType Article -
dc.description.journalRegisteredClass scie -
dc.description.journalRegisteredClass scopus -
dc.description.journalRegisteredClass kci -
dc.subject.keywordPlus LINKED N-ACETYLGLUCOSAMINEAMYOTROPHIC-LATERAL-SCLEROSISGLCNAC MODIFICATIONALPHA-SYNUCLEINNUCLEAR-POREPARKINSONS-DISEASETAU PATHOLOGYGLYCOSYLATIONNEURONSTRANSFERASE -

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.